watch cbsn live by tucker reals april 9 2020 11 40 am cbs news the u s government s national institutes of health launched an official clinical trial of the anti malaria drug that president trump has already touted as a possible game changer in the fight against the new coronavirus the nih s national heart lung and blood institute nhlbi announced thursday that the first patients had been enrolled at vanderbilt university medical center in nashville in the trial of hydroxychloroquine to assess its safety and efficacy in treating covid 19 patients the statement did not say how many patients there had been given the drug already but noted the goal was to enroll more than 500 adults who are currently hospitalized with covid 19 or in an emergency department with anticipated hospitalization across dozens of centers that form a drug trials network across the u s called the petal network all participants in the study will continue to receive clinical care as indicated for their condition those randomized to the experimental intervention will also receive hydroxychloroquine the statement said many u s hospitals are currently using hydroxychloroquine as first line therapy for hospitalized patients with covid 19 despite extremely limited clinical data supporting its effectiveness said lead researcher for the trial dr wesley self of vanderbilt university medical center thus data on hydroxychloroquine for the treatment of covid 19 are urgently needed to inform clinical practice president trump s assertive backing of the drug as a covd 19 treatment before any clinical evidence was available to prove it safe and effective for that use put him at odds with his own senior medical experts preliminary reports suggest potential efficacy in small studies with patients noted nhlbi division of lung diseases director james p kiley in thursday s announcement however we really need clinical trial data to determine whether hydroxychloroquine is effective and safe in treating covid 19 first published on april 9 2020 11 40 am 2020 cbs interactive inc all rights reserved be in the know get the latest breaking news delivered straight to your inbox copyright 2020 cbs interactive inc all rights reserved 